EEM offers exposure to growing economies and global tech giants like TSMC at a cheaper valuation than the US market, having returned 33% last year.
Source Post
These are the 3 ETFs I’m buying in 2026 to beat the S&P 500. 🚀📈 1️⃣ The “Safe” Bio Play: iShares Biotechnol...
Feb 13, 2026
The creator highlights three ETFs to potentially outperform the S&P 500 in 2026: IBB for biotechnology exposure anchored by large companies, EEM for emerging market growth with a focus on tech, and IXC as a global energy hedge. The reel provides past performance data and rationales for each ETF.
Linked Mentions
Tickers discussed in this post
IBB is a market-cap weighted biotech ETF anchored by profitable giants like Amgen and Vertex, offering exposure to gene editing with reduced risk and a 28% return in 2025.
Linked Signals
Tracked calls opened from this post
No linked signals were opened directly from this post.